Chengyi Pharmaceuticals: The company's products, such as Hydrochloride Glucosamine Capsules, are scheduled for continued procurement through the national centralized procurement organization for selected medicines.

2026-02-19 01:29:49

Chengyi Pharmaceutical announces that the company has applied for the continuation of procurement for products whose agreements for the 1st to 8th batches of the national organized centralized procurement have expired. According to the “Proposed Selected Results Table for Continuation Procurement of Drugs with Expired Agreements in the National Organized Centralized Procurement (LC-YPJX-2026-1)” issued by the Continuation Procurement Office, the company’s products—Hydrochloride Glucosamine Capsules, Torasemide Injection, Lidocaine Hydrochloride Injection, and L-Carnitine Injection—are proposed to be selected for this continuation procurement. The procurement period extends until December 31, 2028, covering the entire country.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes